Firms

Inventure
Helsinki, Finland · Stockholm, Sweden · London, United Kingdom
Inventure is a Nordic and Baltic early-stage venture-capital platform founded in2005 by Sami Lampinen and Timo Tirkkonen. It invests across seed and SeriesA, supporting technical founders with follow-on capital and operational expertise. Its published interests include artificial intelligence, deep technology, healthcare, biotechnology, energy, semiconductors, space, software and consumer businesses. The live directory lists ten current investment, operations and communications professionals, with offices in Helsinki, Stockholm and London. Its exact historical and FundI–IV operating manager is Onventure Oy, Finnish businessID1979075-1, a registered AIFM and EuVECA manager. The Finnish Patent and Registration Office’s official register confirms this company, originally named Holtron Partners Oy before2007. Own compliance materials explicitly distinguish the four limited partnerships Inventure Fund Ky, FundIIKy, FundIIIKy and FundIVKy from their respective corporate general partners Inventure Oy, InventureIIOy, InventureIIIOy and InventureIVOy, owned by Onventure. The brand is not a merged fund or a claim that all corporate GP companies are the same legal person. A separate newer Finnish legal company, Inventure Partners Oy3533737-5, is named by the Estonian financial supervisor as the FundV manager. Official PRH registration confirms it is distinct from Onventure. No automatic legal merger, rename or retroactive transfer of historical checks is inferred. FundV’s precise current brand-to-vehicle management and closed-capital announcement remain qualified research until a current primary operating document confirms them; no target is recorded as raised cash. The firm’s July6,2023 primary announcement confirms FundIV’s third and final closing at EUR151million commitments, exceeding its EUR150million target. Own compliance specifies June2023 final close, without an exact day. Earlier fund vehicles and reported capital are recorded with their primary source scope; general manager AUM, LP support commitments and investment-ticket ranges are not new company financing. FundIV’s earlier EUR144million second-close figure is the same fund, not an additional fund. The portfolio includes explainable-AI therapeutics company Abzu, quantum drug-discovery company Algorithmiq, computational protein designer Biomatter, brain-stimulation company Samphire Neuroscience and enterprise-AI infrastructure and semiconductor companies. The firm’s own Abzu card identifies a2021 seed investment; the issuer’s financing history is owned separately and no day, ticket, subscribing fund or personal director cash is inferred from a portfolio card.
- Founded
- 2005
- Type
- Venture capital



















